Effects of elastoviscoplastic properties of mucus on airway closure in healthy and pathological conditions
O. Erken, B. Fazla, F. Roman\`o, J. B. Grotberg, D. Izbassarov, M., Muradoglu

TL;DR
This study models mucus as an elastoviscoplastic material to understand its role in airway closure, revealing how different lung conditions affect stress distribution and closure dynamics.
Contribution
It introduces a rheological model fitting mucus properties in various lung conditions and analyzes the impact of EVP properties on airway closure and stress behavior.
Findings
Higher wall stresses in COPD and CF due to viscoelastic effects
Unyielded elastic phase dominates before airway closure
Stiffer mucus in pathological conditions alters stress relaxation patterns
Abstract
Airway mucus is a complex material with both viscoelastic and viscoplastic properties that vary with healthy and pathological lung conditions. In this study, the effects of these conditions on airway closure are examined in a model problem, where an elastoviscoplastic (EVP) single liquid layer lines the inner wall of a rigid pipe and surrounds the air core. The EVP liquid layer is modelled using the Saramito-HB model. Model parameters are obtained for the mucus in healthy, asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) conditions by fitting the rheological model to experimental data. Then, liquid plug formation is studied by varying the Laplace number and undisturbed liquid film thickness. According to previous studies, airway epithelial cells can be damaged by high peak of the wall stresses and stress gradients during liquid plug formation. Here, we show…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis · Proteoglycans and glycosaminoglycans research · Voice and Speech Disorders
